We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Should I dump my holding in Fundsmith and buy an S&P 500 tracker instead?

Fundsmith’s underperformed because of its lack of exposure to Big Tech. Could an S&P 500 tracker fund be the solution for Edward Sheldon?

| More on:
Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

I’ve held the Fundsmith Equity investment fund in my Self-Invested Personal Pension (SIPP) for many years. And over the long run, it’s made me quite a bit of money. However, the fund’s been underperforming the broader market. This has got me wondering whether I should dump it and buy a S&P 500 tracker fund instead.

Underperforming the market

It has been a while since Fundsmith beat the market on an annual basis. The last time was in 2020 when it returned 18.3% versus 12.3% for the MSCI World index.

Should you buy Vanguard Funds Public - Vanguard S&P 500 Ucits ETF shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

I’ve put the returns since then in the table below. As you can see, it’s lagged the MSCI World index significantly since 2022.

YearFundsmithMSCI World index
202122.1%22.9%
2022-13.8%-7.8%
202312.4%16.8%
Jan to Oct 2024 6.9%15.5%
Source: Fundsmith

This underperformance is disappointing. Especially when you consider the fund has ongoing charges of 0.94% on Hargreaves Lansdown (my broker).

The problem

The issue here’s pretty clear – Fundsmith’s an underweight mega-cap technology stocks and this is hurting its performance. In recent years, these stocks have generated huge returns. And Fundsmith hasn’t fully participated in the rally.

It does have large positions in Microsoft and Meta Platforms, has a growing position in Alphabet and a small holding in Apple. But it doesn’t have exposure to Amazon (it did buy this stock a few years ago but sold it at the wrong time), Nvidia, or Tesla.

More tech exposure

Buying an S&P 500 tracker fund like the Vanguard S&P 500 UCITS ETF (LSE: VUSA) would solve this issue.

This product would give me a ton of exposure to mega-cap tech stocks such as Apple, Nvidia and Amazon as these kinds of stocks have large weightings in the S&P 500, as the table below shows:

Source: Vanguard

And I’d get them all for a low ongoing fee of just 0.07%. Additionally, my platform fees with Hargreaves Lansdown would be lower.

New risks

Having said that, buying this ETF would expose me to new risks. For starters, there would be more geographic risk. With an S&P 500 tracker, 100% of the product’s allocated to the US market. With Fundsmith – which is a global equity product – the US represents about 73% of the portfolio currently.

It’s worth noting here that the US market has had a huge run over the last two years and it now looks quite expensive. So there’s a chance we could see some volatility at some point in the near future.

There would also be more technology sector risk for me. I already own shares in five of the ‘Magnificent 7’ directly, so if I were to buy this ETF, my portfolio could take a big hit if the tech sector had a meltdown (which seems to happen every few years).

In theory, holding on to Fundsmith should provide me with some protection against a US market or Tech sector meltdown. But there are no guarantees here, of course.

My move now

For now, I’m going to hold on to Fundsmith. I like the fund’s focus on quality stocks and I see it as a good hedge against mainstream market risks.

That said, I will be watching the performance closely. For the fees I’m paying, it needs to start delivering again.

Edward Sheldon has positions in Alphabet, Amazon, Apple, Microsoft, and Nvidia. The Motley Fool UK has recommended Alphabet, Amazon, Apple, Hargreaves Lansdown Plc, Meta Platforms, Microsoft, Nvidia, and Tesla. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A row of satellite radars at night
Investing Articles

This ex-penny stock has crushed Rolls-Royce shares over 5 years! Is there more to come?

With all eyes on Rolls-Royce shares, this growth share with a connection to SpaceX might have gone unnoticed by a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »